Royce & Associates’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-590,923
| Closed | -$1.61M | – | 1032 |
|
|
2021
Q4 | $1.61M | Sell |
590,923
-183,000
| -24% | -$674K | 0.01% | 755 |
|
|
2021
Q3 | $3.68M | Sell |
773,923
-42,973
| -5% | -$314K | 0.03% | 641 |
|
|
2021
Q2 | $6.59M | Sell |
816,896
-93,900
| -10% | -$782K | 0.05% | 548 |
|
|
2021
Q1 | $7.3M | Sell |
910,796
-204,030
| -18% | -$1.9M | 0.05% | 522 |
|
|
2020
Q4 | $9.98M | Sell |
1,114,826
-257,706
| -19% | -$2.14M | 0.08% | 370 |
|
|
2020
Q3 | $10.3M | Sell |
1,372,532
-15,000
| -1% | -$104K | 0.11% | 273 |
|
|
2020
Q2 | $8.84M | Sell |
1,387,532
-87,488
| -6% | -$585K | 0.1% | 297 |
|
|
2020
Q1 | $11M | Sell |
1,475,020
-571,272
| -28% | -$4.43M | 0.15% | 184 |
|
|
2019
Q4 | $18.5M | Sell |
2,046,292
-9,075
| -0.4% | -$76.3K | 0.16% | 166 |
|
|
2019
Q3 | $15.4M | Sell |
2,055,367
-106,967
| -5% | -$600K | 0.14% | 204 |
|
|
2019
Q2 | $11.2M | Buy |
2,162,334
+37,500
| +2% | +$244K | 0.1% | 296 |
|
|
2019
Q1 | $17.8M | Sell |
2,124,834
-100,097
| -4% | -$721K | 0.15% | 177 |
|
|
2018
Q4 | $9.57M | Buy |
2,224,931
+485,898
| +28% | +$4.29M | 0.09% | 332 |
|
|
2018
Q3 | $25.3M | Buy |
1,739,033
+149,500
| +9% | +$2.48M | 0.17% | 150 |
|
|
2018
Q2 | $29.6M | Buy |
1,589,533
+37,100
| +2% | +$671K | 0.2% | 122 |
|
|
2018
Q1 | $27M | Sell |
1,552,433
-22,300
| -1% | -$393K | 0.19% | 131 |
|
|
2017
Q4 | $26.5M | Buy |
1,574,733
+160,564
| +11% | +$2.61M | 0.18% | 146 |
|
|
2017
Q3 | $22.3M | Buy |
1,414,169
+59,430
| +4% | +$848K | 0.15% | 205 |
|
|
2017
Q2 | $17.9M | Buy |
1,354,739
+143,027
| +12% | +$1.88M | 0.12% | 245 |
|
|
2017
Q1 | $14.4M | Buy |
1,211,712
+126,982
| +12% | +$1.52M | 0.09% | 293 |
|
|
2016
Q4 | $14.2M | Buy |
1,084,730
+158,880
| +17% | +$1.83M | 0.09% | 294 |
|
|
2016
Q3 | $10.3M | Buy |
925,850
+53,000
| +6% | +$638K | 0.07% | 366 |
|
|
2016
Q2 | $10.6M | Sell |
872,850
-47,800
| -5% | -$563K | 0.07% | 368 |
|
|
2016
Q1 | $12.1M | Sell |
920,650
-421,756
| -31% | -$5.98M | 0.08% | 341 |
|
|
2015
Q4 | $23.3M | Sell |
1,342,406
-6,076
| -0.5% | -$110K | 0.14% | 198 |
|
|
2015
Q3 | $19.5M | Buy |
1,348,482
+101,440
| +8% | +$1.77M | 0.1% | 247 |
|
|
2015
Q2 | $27M | Sell |
1,247,042
-96,300
| -7% | -$2.04M | 0.11% | 223 |
|
|
2015
Q1 | $26.1M | Sell |
1,343,342
-192,400
| -13% | -$3.33M | 0.1% | 259 |
|
|
2014
Q4 | $25.7M | Sell |
1,535,742
-144,294
| -9% | -$2.19M | 0.09% | 287 |
|
|
2014
Q3 | $19.8M | Sell |
1,680,036
-9,400
| -0.6% | -$143K | 0.07% | 350 |
|
|
2014
Q2 | $31M | Buy |
1,689,436
+360,275
| +27% | +$6.12M | 0.09% | 262 |
|
|
2014
Q1 | $25.3M | Sell |
1,329,161
-126,600
| -9% | -$2.6M | 0.07% | 314 |
|
|
2013
Q4 | $33.8M | Buy |
1,455,761
+121,500
| +9% | +$2.52M | 0.1% | 250 |
|
|
2013
Q3 | $23M | Buy |
1,334,261
+42,700
| +3% | +$678K | 0.07% | 326 |
|
|
2013
Q2 | $18.5M | Buy |
+1,291,561
| New | +$17.9M | 0.06% | 379 |
|
Other funds holding IVC
RCM
NRC
Royce & Associates's IVC Position: Q1 2022 in Review
Royce & Associates sold out of Invacare Corporation (IVC) in Q1 2022, closing a stake of 590,923 shares — an estimated $1.61M sold.
Royce & Associates first reported a position in IVC in Q2 2013 and held it in 35 quarters. The position peaked at $33.8M in Q4 2013. 109 funds tracked by Wall St. Rank hold IVC as of Q1 2022.
- Royce & Associates reported no remaining Invacare Corporation position as of Q1 2022 after selling out during the quarter.
- Royce & Associates sold 590,923 Invacare Corporation shares in Q1 2022, an estimated $1.61M.
- Royce & Associates first reported a position in Invacare Corporation in Q2 2013 and held it in 35 quarters.
- Royce & Associates's Invacare Corporation position peaked at $33.8M in Q4 2013.
- 109 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2022.
Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.